| 000 | 01135 a2200313 4500 | ||
|---|---|---|---|
| 005 | 20250516030833.0 | ||
| 264 | 0 | _c20110518 | |
| 008 | 201105s 0 0 eng d | ||
| 022 | _a1532-8708 | ||
| 024 | 7 |
_a10.1053/j.seminoncol.2011.01.002 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _ade Souza, Jonas A | |
| 245 | 0 | 0 |
_aCYP2D6 genotyping and tamoxifen: an unfinished story in the quest for personalized medicine. _h[electronic resource] |
| 260 |
_bSeminars in oncology _cApr 2011 |
||
| 300 |
_a263-73 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aBreast Neoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aCytochrome P-450 CYP2D6 _xgenetics |
| 650 | 0 | 4 | _aCytochrome P-450 CYP2D6 Inhibitors |
| 650 | 0 | 4 |
_aEstrogen Antagonists _xtherapeutic use |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGenotype |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aPrecision Medicine |
| 650 | 0 | 4 |
_aTamoxifen _xmetabolism |
| 700 | 1 | _aOlopade, Olufunmilayo I | |
| 773 | 0 |
_tSeminars in oncology _gvol. 38 _gno. 2 _gp. 263-73 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1053/j.seminoncol.2011.01.002 _zAvailable from publisher's website |
| 999 |
_c20691544 _d20691544 |
||